Español
Nederlands
Italiano
Deutsch
Français
Português
Laboratorio Reig Jofre has scheduled the disbursement of its dividend of 0,04 euros per share, yielding 1.42%, for May 23, 2024.
The May 3, 2024 is the ex-dividend date. So if you wish to receive Laboratorio Reig Jofre dividends, you must buy one day before this date.
The dividend issued by Laboratorio Reig Jofre on May 24, 2023 amounted to 0.04 euros.
Reig Jofre rewards its associates according to the conditions approved by the General Shareholders' Meeting, offering two possibilities, one of which is the flexible dividend or "scrip dividend", which allows investors the possibility of receiving bonus shares in the company.
Another option is to receive the interest payment in cash, which is made annually in a single installment, at a fixed price, usually between the months of May and September, with a dividend yield of 1.60% and a payout of approximately 38%.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio Laboratorio Reig Jofre Dividends
Dividend calendar of Laboratorio Reig Jofre
These are the most important events of the Laboratorio Reig Jofre calendar in 2024:
| Event | Day |
|---|---|
| Last trading date | May 2, 2024 |
| Ex-Dividend (Ex-Date) | May 3, 2024 |
| Record date | May 22, 2024 |
| Date of payment | May 23, 2024 |
Dividend history of Laboratorio Reig Jofre
In this table you can see the complete history:
| Year | Ex-Dividend | Amount | Total |
|---|---|---|---|
| 2023 | 05/05/2023 | 0.04 € | 0.04 € |
| 2022 | 06/15/2022 | 0.04 € | 0.04 € |
| 2021 | 06/10/2021 | 0.045 € | 0.045 € |
| 2020 | 09/16/2020 | 0.039 € | 0.039 € |
| 2019 | 05/07/2019 | 0.045 € | 0.045 € |
| 2018 | 06/15/2018 | 0.046 € | 0.046 € |
| 2013 | 06/06/2013 | 0.74 € | 0.74 € |
Information about Laboratorio Reig Jofre
Reig Jofre, is a company dedicated to the pharmaceutical industry specialized in the research, development, manufacture and marketing of medicines and food supplements.
It was founded in 1929 in Barcelona and currently has four production and development centers in Europe, although its products are available in more than 70 countries, with its own subsidiaries in 8 of them, France, Portugal, Belgium, United Kingdom, Poland, Sweden, Singapore and Spain, supported by more than 130 commercial partners.
Its activity is structured in three business units, "Pharmaceutical Technologies", a unit dedicated to injectable drugs and antibiotics, "Specialty Pharmacare", specialized in dermatology, women's health and osteoarticular health, and "Consumer Healthcare", dedicated to the manufacture of food supplements, topical disinfectants and alcohols.
Frequently asked questions about Laboratorio Reig Jofre dividends
Laboratorio Reig Jofre pays dividends on a Anual basis.
Laboratorio Reig Jofre is listed on the and is part of the Ibex Small.
Laboratorio Reig Jofre has the Ticker or stock code RJF.
The CEO of Laboratorio Reig Jofre in 2024 is Mr. Ignasi Biosca Reig.
Laboratorio Reig Jofre does not have a growing dividend program. Dividends have not shown a steady growth in the last 5 years.